Ascendis Pharma A/S (ASND) has an average rating of buy and mean price target of $310.61, according to analysts polled by FactSet.
What else is happening in Research?
Research
Wolfe Research Downgrades Intuit to Peer Perform From Outperform
Intuit (INTU) has an average rating of overweight and mean price target of $425.93, according to analysts polled by FactSet.Price: $344.52, Change: $-12.95, Percent Change: -3.62%
$INTU
Research
Tigress Financial Initiates Jersey Mike's Subs at Buy With $29 Price Target
Jersey Mike's Subs (JMKE) has an average rating of buy and mean price target of $28.36, according to analysts polled by FactSet.Price: $22.27, Change: $+0.06, Percent Change: +0.27%
$JMKE
Research
UBS Downgrades SAP to Neutral From Buy
UBS Downgrades SAP to Neutral From Buy
$SAP